Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Multidomain peptide (MDP) nanofibers form scaffolds for presenting bioactive cues.
• Supramolecular composite hydrogels can be created by self-assembly of MDPs and growth-factor-loaded liposomes.
• These composites serve as delivery vehicles with controlled release capabilities.

Purpose of the Study:

• To examine the controlled release of placental growth factor-1 (PlGF-1) from MDP-based hydrogels.
• To evaluate the angiogenic potential of released PlGF-1.
• To assess the efficacy of MDP(Lipo) hydrogels as injectable platforms for treating ischemic diseases.

Main Methods:

• Orthogonal self-assembly of MDPs and liposomes to create composite hydrogels.
• Loading of PlGF-1 either directly into MDP matrices or within liposomes integrated into MDP gels.
• In vitro assessment of HUVEC VEGF receptor activation and in vivo evaluation of neovascularization.

Main Results:

• MDP(Lipo) hydrogels demonstrated controlled release of PlGF-1.
• PlGF-1 released from MDP(Lipo) modulated HUVEC VEGF receptor activation in vitro.
• Robust vessel formation and high neovascular maturity were observed in vivo with MDP(Lipo) hydrogels.

Conclusions:

• MDP(Lipo) hydrogels provide a biocompatible and injectable platform for tailored drug delivery.
• These hydrogels effectively promote angiogenic responses through controlled release of growth factors.
• MDP(Lipo) hydrogels show promise for treating ischemic tissue diseases.